Jeffrey A. Bailey - 21 Nov 2024 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
Director
Signature
/s/ Jeffrey A. Bailey
Issuer symbol
AUPH
Transactions as of
21 Nov 2024
Net transactions value
$0
Form type
4
Filing time
25 Nov 2024, 16:30:53 UTC
Previous filing
12 Nov 2024
Next filing
16 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUPH Common Shares Award $0 +12,135 +91% $0.000000 25,491 21 Nov 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUPH Director Stock Option (right to buy) Award $0 +18,641 $0.000000 18,641 21 Nov 2024 Common Shares 18,641 $8.24 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents grant of Restricted Stock Units (RSUs) payable solely in common shares of the Issuer. The shares subject to the RSUs shall vest one year from date of grant.
F2 The options shall vest one year from date of grant.